The study and its comparison
A blinded trial involving 107 adults with episodic migraine compared dry ginger-extract capsules with placebo after a baseline observation month. Treatment continued for three months and participants kept migraine diaries. [1]
The proportion achieving at least a fifty-percent reduction in attacks did not differ between groups. Severe-pain days, acute medication use and attack duration improved in both groups without a significant ginger advantage. [1]
What the finding establishes
Improvement during a trial can occur without a treatment-specific effect. These findings apply to the tested preventive regimen, not every acute headache treatment or ginger tea preparation. Funding and conflicts were not established from the abstract. The result provides no basis for replacing an effective preventive plan with this extract simply because ginger has other studied uses. [1]
A hypothetical distinction
Imagine both groups report fewer headaches after joining a study. The between-group comparison determines whether the tested treatment added benefit.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Double-blind placebo-controlled randomized clinical trial of ginger ( Zingiber officinale Rosc. ) in the prophylactic treatment of migraine.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.